净利暴增超50%!CXO龙头药明生物,否极泰来

侃见财经
25 Jul

医药行业的新周期已经到来。尤其是创新药以及CXO赛道,外部干扰因素正在逐渐消散,内生性的增长逻辑正在重新驱动行业走向新的景气周期。近期,CXO龙头企业之一的药明生物发布了2025年中期正面盈利预告,预告显示,根据对截至2025年6月30日止六个月未经审核综合管理账目的初步评估,预计公司收益将同比增长约16%,毛利率同比提升约3.6%。报告期内,公司利润及归属于公司权益股东的利润预计将分别同比增长约...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10